AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

COVID-19 is a novel disease caused by SARS-CoV-2 which has conquered the world rapidly resulting in a pandemic that massively impacts our health, social activities, and economy. It is likely that vaccination is the only way to form “herd immunity” and restore the world to normal. Here we developed a...

Description complète

Détails bibliographiques
Auteurs principaux: Xuelan Liu, Xinyue Chang, Dominik Rothen, Mariliza Derveni, Pascal Krenger, Salony Roongta, Edward Wright, Monique Vogel, Kaspars Tars, Mona O. Mohsen, Martin F. Bachmann
Format: Article
Langue:English
Publié: MDPI AG 2021-04-01
Collection:Vaccines
Sujets:
Accès en ligne:https://www.mdpi.com/2076-393X/9/4/403